Drugs giant GlaxoSmithKline (IW 1000/124) announced on August 1 that it will form a joint venture with Google's parent company Alphabet to research and develop so-called bioelectronic medicines.
GSK has agreed with Verily Life Sciences (formerly Google Life Sciences) to create a new company called Galvani Bioelectronics.
The venture will be headquartered in Britain and will receive a total investment of up to $714 million over seven years.
Image: GlaxoSmithKline - http://www.industryweek.com
